Literature DB >> 3182419

Rational use of antimicrobial agents and diagnostic microbiology facilities.

A W Sturm1.   

Abstract

During a two month period doctors' motives for prescribing antimicrobial chemotherapy were studied. Of the 1775 patients admitted, 374 (21%) received antimicrobial agents for 384 infective episodes. In 44 (11.5%) no infection could be subsequently proven. Of the remaining 340, drug selection was based on a susceptibility report in 120 (35%), on the advice of a medical microbiologist with the aid of a Gram stain in 66 (19%), and without this assistance in 51 (15%). In 103 (30%) episodes the clinician selected the agent without advice and laboratory tests. Infection was proven in 237 of 238 episodes in which therapy was started following a known susceptibility result or the advice of the microbiologist. Four (1.7%) of these later required a change of therapy, compared with 22 (21%) of the 103 courses started without such help (P less than 0.0005). This study has shown that the use of the laboratory and consultation with a medical microbiologist improves the rational prescribing of antimicrobial chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182419     DOI: 10.1093/jac/22.2.257

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.

Authors:  A W Sturm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

2.  The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia.

Authors:  R J Cunney; E B McNamara; N Alansari; B Loo; E G Smyth
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

3.  Use of laboratory test results in patient management by clinicians in Malawi.

Authors:  Kundai Moyo; Carol Porter; Ben Chilima; Reuben Mwenda; Mark Kabue; Lutho Zungu; Abdoulaye Sarr
Journal:  Afr J Lab Med       Date:  2015-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.